BiondVax is developing an innovative, proprietary Universal Flu Vaccine to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains, such as Swine flu and Avian flu.
BiondVax’s proprietary technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.
BiondVax is currently testing its lead product, the Multimeric-001 vaccine, in two Phase I/II clinical trials.
ONE Vaccine For ALLflu strains:
Seasonal & Pandemic ONE Vaccine Multi-season, long-lasting protection
